Implantable brain device aims to tame Drug-Resistant seizures
NCT ID NCT07301346
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called EASEE® that is implanted under the skin and above the skull to stimulate the brain and reduce seizures in people with drug-resistant focal epilepsy. Two hundred adults will receive the implant, and half will have the stimulation turned on for 6 months to compare seizure reduction. The goal is to see if the device is safe and effective over 18 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable brain stimulator (EASEE® System)
What this could lead to
If it works, this could offer a new, minimally invasive option to reduce seizures in people with epilepsy that doesn't respond to medication.
What could go wrong
This is an early pivotal study with 200 participants, so results may not apply to everyone. Risks include surgical complications and the device may not reduce seizures for all.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Mapping for SUDEP Risk in Epilepsy – NCT07599150
- Weak Electric Fields & Brain Activity in Epileps NCT05250713
- Personalized tDCS for Drug-Resistant Epilepsy (NCT04782869)
- MicroEPI: Recording Brain Neurons During Seizure NCT05335187
- New MEG Sensor Study for Epilepsy (NCT04694313)
- Multimodal Study for Drug-Resistant Epilepsy Dia NCT06794606
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••